156 related articles for article (PubMed ID: 26248653)
1. Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes.
Kadakia KC; Loprinzi CL; Atherton PJ; Fee-Schroeder KC; Sood A; Barton DL
Support Care Cancer; 2016 Mar; 24(3):1061-9. PubMed ID: 26248653
[TBL] [Abstract][Full Text] [Related]
2. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.
Park H; Qin R; Smith TJ; Atherton PJ; Barton DL; Sturtz K; Dakhil SR; Anderson DM; Flynn K; Puttabasavaiah S; Le-Lindqwister NA; Padula GD; Loprinzi CL
Menopause; 2015 Jun; 22(6):627-32. PubMed ID: 25423327
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam for the treatment of hot flashes: a phase II study.
Thompson S; Bardia A; Tan A; Barton DL; Kottschade L; Sloan JA; Christensen B; Smith D; Loprinzi CL
Support Care Cancer; 2008 Jan; 16(1):75-82. PubMed ID: 17598133
[TBL] [Abstract][Full Text] [Related]
5. Effect of L-methionine on hot flashes in postmenopausal women: a randomized controlled trial.
Guttuso T; McDermott MP; Ng P; Kieburtz K
Menopause; 2009; 16(5):1004-8. PubMed ID: 19407666
[TBL] [Abstract][Full Text] [Related]
6. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
Barton DL; LaVasseur BI; Sloan JA; Stawis AN; Flynn KA; Dyar M; Johnson DB; Atherton PJ; Diekmann B; Loprinzi CL
J Clin Oncol; 2010 Jul; 28(20):3278-83. PubMed ID: 20498389
[TBL] [Abstract][Full Text] [Related]
7. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1.
Loprinzi CL; Qin R; Balcueva EP; Flynn KA; Rowland KM; Graham DL; Erwin NK; Dakhil SR; Jurgens DJ; Burger KN
J Clin Oncol; 2010 Feb; 28(4):641-7. PubMed ID: 19901102
[TBL] [Abstract][Full Text] [Related]
8. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
Pockaj BA; Gallagher JG; Loprinzi CL; Stella PJ; Barton DL; Sloan JA; Lavasseur BI; Rao RM; Fitch TR; Rowland KM; Novotny PJ; Flynn PJ; Richelson E; Fauq AH
J Clin Oncol; 2006 Jun; 24(18):2836-41. PubMed ID: 16782922
[TBL] [Abstract][Full Text] [Related]
9. Phase II Evaluation of Desipramine for the Treatment of Hot Flashes.
Barton DL; Loprinzi CL; Atherton P; Raymond J; Shanafelt T; Hines S; Palmieri F; Rummans T; Adjei AA; Sloan J
Support Cancer Ther; 2007 Sep; 4(4):219-24. PubMed ID: 18632520
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
[TBL] [Abstract][Full Text] [Related]
11. Pilot evaluation of black cohosh for the treatment of hot flashes in women.
Pockaj BA; Loprinzi CL; Sloan JA; Novotny PJ; Barton DL; Hagenmaier A; Zhang H; Lambert GH; Reeser KA; Wisbey JA
Cancer Invest; 2004; 22(4):515-21. PubMed ID: 15565808
[TBL] [Abstract][Full Text] [Related]
12. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
[TBL] [Abstract][Full Text] [Related]
13. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
Stearns V; Slack R; Greep N; Henry-Tilman R; Osborne M; Bunnell C; Ullmer L; Gallagher A; Cullen J; Gehan E; Hayes DF; Isaacs C
J Clin Oncol; 2005 Oct; 23(28):6919-30. PubMed ID: 16192581
[TBL] [Abstract][Full Text] [Related]
14. Phase III evaluation of fluoxetine for treatment of hot flashes.
Loprinzi CL; Sloan JA; Perez EA; Quella SK; Stella PJ; Mailliard JA; Halyard MY; Pruthi S; Novotny PJ; Rummans TA
J Clin Oncol; 2002 Mar; 20(6):1578-83. PubMed ID: 11896107
[TBL] [Abstract][Full Text] [Related]
15. The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial.
Farzaneh F; Fatehi S; Sohrabi MR; Alizadeh K
Arch Gynecol Obstet; 2013 Nov; 288(5):1075-9. PubMed ID: 23625331
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.
Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ
Lancet; 2005 Sep 3-9; 366(9488):818-24. PubMed ID: 16139656
[TBL] [Abstract][Full Text] [Related]
17. Centrally active nonhormonal hot flash therapies.
Loprinzi CL; Stearns V; Barton D
Am J Med; 2005 Dec; 118 Suppl 12B():118-23. PubMed ID: 16414336
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
Toulis KA; Tzellos T; Kouvelas D; Goulis DG
Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
[TBL] [Abstract][Full Text] [Related]
19. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
20. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.
Van Patten CL; Olivotto IA; Chambers GK; Gelmon KA; Hislop TG; Templeton E; Wattie A; Prior JC
J Clin Oncol; 2002 Mar; 20(6):1449-55. PubMed ID: 11896091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
